Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA

BACKGROUND: Chronic kidney disease-mineral and bone disorder (CKD-MBD), a complication of chronic kidney disease, has been linked to reduced quality and length of life. High serum phosphate levels that result from CKD-MBD require phosphate-lowering agents, also known as phosphate binders. The object...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekercioglu, Nigar, Angeliki Veroniki, Argie, Thabane, Lehana, Busse, Jason W., Akhtar-Danesh, Noori, Iorio, Alfonso, Cruz Lopes, Luciane, Guyatt, Gordon H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331957/
https://www.ncbi.nlm.nih.gov/pubmed/28248961
http://dx.doi.org/10.1371/journal.pone.0171028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331957/
https://www.ncbi.nlm.nih.gov/pubmed/28248961
http://dx.doi.org/10.1371/journal.pone.0171028

Ejemplares similares